Agency Information Collection Activities: Submission for OMB Review; Comment Request, 71367-71368 [2023-22791]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
Respondent
Form
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Non-responding SSPs ...................................
Non-Response Survey Item ..........................
1000
1
2/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–22777 Filed 10–13–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10241 and CMS–
10717]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by November 15,
2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
SUMMARY:
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
AGENCY:
ddrumheller on DSK120RN23PROD with NOTICES1
71367
William Parham at (410) 786–4669.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Survey of Retail
Prices; Use: This information collection
request provides for a survey of the
average acquisition costs of all covered
outpatient drugs purchased by retail
community pharmacies. CMS may
contract with a vendor to conduct
monthly surveys of retail prices for
covered outpatient drugs. Such prices
represent a nationwide average of
consumer purchase prices, net of
discounts and rebates. The contractor
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
shall provide notification when a drug
product becomes generally available
and that the contract includes such
terms and conditions as the Secretary
shall specify, including a requirement
that the vendor monitor the
marketplace. CMS has developed a
National Average Drug Acquisition Cost
(NADAC) for states to consider when
developing reimbursement
methodology. The NADAC is a pricing
benchmark that is based on the national
average costs that pharmacies pay to
acquire Medicaid covered outpatient
drugs. This pricing benchmark is based
on drug acquisition costs collected
directly from pharmacies through a
nationwide survey process. This survey
is conducted on a monthly basis to
ensure that the NADAC reference file
remains current and up-to-date. Form
Number: CMS–10241 (OMB control
number 0938–1041); Frequency:
Monthly; Affected Public: Private sector
(Business or other for-profits); Number
of Respondents: 72,000; Total Annual
Responses: 72,000; Total Annual Hours:
36,000. (For policy questions regarding
this collection contact: Robert Giles at
667–290–8626.)
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare Part C
and Part D Program Audit and IndustryWide Part C Timeliness Monitoring
Project (TMP) Protocols; Use: Under the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 and implementing regulations at
42 CFR parts 422 and 423, Medicare
Part D plan sponsors and Medicare
Advantage organizations are required to
comply with all Medicare Parts C and D
program requirements. CMS’ annual
audit plan ensures that we evaluate
sponsoring organizations’ compliance
with these requirements by conducting
program audits that focus on high-risk
areas that have the greatest potential for
beneficiary harm. As such, CMS has
developed the following audit protocols
for use by sponsoring organizations to
prepare for their audit:
• Compliance Program Effectiveness
(CPE)
• Part D Formulary and Benefit
Administration (FA)
• Part D Coverage Determinations,
Appeals, and Grievances (CDAG)
E:\FR\FM\16OCN1.SGM
16OCN1
71368
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices
• Part C Organization Determinations,
Appeals, and Grievances (ODAG)
• Special Needs Plans Care
Coordination (SNPCC)
ddrumheller on DSK120RN23PROD with NOTICES1
CMS generally conducts program
audits at the parent organization level in
an effort to reduce burden and, for
routine audits, subjects each sponsoring
organization to all applicable program
area protocols. For example, if a
sponsoring organization does not offer a
special needs plan, or an accrediting
organization has deemed a special needs
plan compliant with CMS regulations
and standards, CMS would not apply
the SNPCC protocol. Likewise, CMS
would not apply the ODAG audit
protocol to an organization that offers
only a standalone prescription drug
plan since that organization does not
offer the MA benefit. Conversely, ad hoc
audits resulting from referral may be
limited in scope and, therefore, all
program area protocols may not be
applied.
The information gathered during this
program audit will be used by the
Medicare Parts C and D Oversight and
Enforcement Group (MOEG) within the
Center for Medicare (CM) and CMS
Regional Offices to assess sponsoring
organizations’ compliance with
Medicare program requirements. If
outliers or other data anomalies are
detected, Regional Offices will work in
collaboration with MOEG and other
divisions within CMS for follow-up and
resolution. Additionally, MA and Part D
organizations will receive the audit
results and will be required to
implement corrective action to correct
any identified deficiencies. Form
Number: CMS–10717 (OMB control
number: 0938–1395); Frequency: Yearly;
Affected Public: Private Sector, State,
Local, or Tribal Governments, Federal
Government, Business or other forprofits, Not-for-Profit Institutions;
Number of Respondents: 182; Total
Annual Responses: 182; Total Annual
Hours: 36,444. (For policy questions
regarding this collection contact
Matthew Guerand, at 303–844–7120.)
Dated: October 11, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–22791 Filed 10–13–23; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
17:03 Oct 13, 2023
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Fiscal Year 2023 Health
Center Program COVID–19 HHS Bridge
Access Program Funding Awards
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of funding awards.
submit data on program activities
through the HRSA Health Center
COVID–19 survey as required, as well as
periodic progress reports.
Carole Johnson,
Administrator.
[FR Doc. 2023–22751 Filed 10–13–23; 8:45 am]
BILLING CODE 4165–15–P
AGENCY:
In support of the HHS Bridge
Access Program for COVID–19 Vaccines
and Treatments, HRSA provided more
than $81 million in one-time funding to
all current Health Center Program
operational (H80) award recipients and
to health center look-alikes that
previously received American Rescue
Plan funding (L2C awards).
FOR FURTHER INFORMATION CONTACT:
Olivia Shockey, Expansion Division
Director, HRSA, at oshockey@hrsa.gov
and (301) 594–4300.
SUPPLEMENTARY INFORMATION:
Intended Recipient of the Award: The
total amount of funding, number of
awards, and award recipients can be
found here: https://bphc.hrsa.gov/
funding/coronavirus-related-funding/
covid-19-bridge-funding/fy-2023awards.
Project Period: September 1, 2023—
December 31, 2024.
CFDA Number: 93.527.
Authority: Section 2401 of the
American Rescue Plan Act of 2021,
Public Law 117–2.
Justification: The end of the declared
COVID–19 Public Health Emergency
and associated transition to commercial
access to vaccines and therapeutics
impacts the capacity of health centers to
maintain essential COVID–19 related
services for their patients, including but
not limited to health center patients
who lack health insurance. Health
centers will use one-time Bridge
funding to support uninsured and
underinsured patients and residents of
their communities with needs such as
COVID–19 vaccination and
therapeutics, enabling/patient support
services (such as outreach, education,
enrollment assistance, transportation,
translation, and care coordination) to
support COVID–19 related services;
community COVID–19 vaccination
events; and, supplies and personnel
who support COVID–19 related services
and care delivery, including personnel
costs necessary to develop, support, or
expand collaborations, including
collaborations with state/jurisdiction
immunization programs. Recipients will
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council provides advice on
how to prevent or reduce the burden of
Alzheimer’s disease and related
dementias (ADRD) on people with the
disease and their caregivers. During the
meeting on October 30, 2023, the
Advisory Council will welcome a new
cohort of members and hear updates
from federal agencies on key activities
over the last quarter. A panel will
present information on interventions to
reduce the risk of developing dementia.
DATES: The meeting will be held
virtually on October 30 from 12 p.m. to
4:30 p.m. EDT.
ADDRESSES: The meeting will be virtual.
It will stream live at www.hhs.gov/live.
Comments: Time is allocated on the
agenda to hear public comments from 4
p.m. to 4:30 p.m. The time for oral
comments will be limited to two (2)
minutes per individual. In order to
provide a public comment, please
register by emailing your name to
napa@hhs.gov by Thursday, October 26.
Registered commenters will receive both
a dial-in number and a link to join the
meeting virtually; individuals will have
the choice to either join virtually via the
link, or to call in only by using the dialin number. Note: There may be a 30–45
second delay in the livestream video
presentation of the conference. For this
reason, if you have pre-registered to
submit a public comment, it is
important to connect to the meeting by
3:45 p.m. to ensure that you do not miss
your name and allotted time when
called. If you miss your name and
allotted time to speak, you may not be
able to make your public comment. All
participant audio lines will be muted for
the duration of the meeting and only
unmuted by the Host at the time of the
SUMMARY:
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 88, Number 198 (Monday, October 16, 2023)]
[Notices]
[Pages 71367-71368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10241 and CMS-10717]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by November 15, 2023.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Survey of Retail
Prices; Use: This information collection request provides for a survey
of the average acquisition costs of all covered outpatient drugs
purchased by retail community pharmacies. CMS may contract with a
vendor to conduct monthly surveys of retail prices for covered
outpatient drugs. Such prices represent a nationwide average of
consumer purchase prices, net of discounts and rebates. The contractor
shall provide notification when a drug product becomes generally
available and that the contract includes such terms and conditions as
the Secretary shall specify, including a requirement that the vendor
monitor the marketplace. CMS has developed a National Average Drug
Acquisition Cost (NADAC) for states to consider when developing
reimbursement methodology. The NADAC is a pricing benchmark that is
based on the national average costs that pharmacies pay to acquire
Medicaid covered outpatient drugs. This pricing benchmark is based on
drug acquisition costs collected directly from pharmacies through a
nationwide survey process. This survey is conducted on a monthly basis
to ensure that the NADAC reference file remains current and up-to-date.
Form Number: CMS-10241 (OMB control number 0938-1041); Frequency:
Monthly; Affected Public: Private sector (Business or other for-
profits); Number of Respondents: 72,000; Total Annual Responses:
72,000; Total Annual Hours: 36,000. (For policy questions regarding
this collection contact: Robert Giles at 667-290-8626.)
2. Type of Information Collection Request: Extension of a currently
approved collection; Title of Information Collection: Medicare Part C
and Part D Program Audit and Industry-Wide Part C Timeliness Monitoring
Project (TMP) Protocols; Use: Under the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 and implementing regulations
at 42 CFR parts 422 and 423, Medicare Part D plan sponsors and Medicare
Advantage organizations are required to comply with all Medicare Parts
C and D program requirements. CMS' annual audit plan ensures that we
evaluate sponsoring organizations' compliance with these requirements
by conducting program audits that focus on high-risk areas that have
the greatest potential for beneficiary harm. As such, CMS has developed
the following audit protocols for use by sponsoring organizations to
prepare for their audit:
Compliance Program Effectiveness (CPE)
Part D Formulary and Benefit Administration (FA)
Part D Coverage Determinations, Appeals, and Grievances (CDAG)
[[Page 71368]]
Part C Organization Determinations, Appeals, and Grievances
(ODAG)
Special Needs Plans Care Coordination (SNPCC)
CMS generally conducts program audits at the parent organization
level in an effort to reduce burden and, for routine audits, subjects
each sponsoring organization to all applicable program area protocols.
For example, if a sponsoring organization does not offer a special
needs plan, or an accrediting organization has deemed a special needs
plan compliant with CMS regulations and standards, CMS would not apply
the SNPCC protocol. Likewise, CMS would not apply the ODAG audit
protocol to an organization that offers only a standalone prescription
drug plan since that organization does not offer the MA benefit.
Conversely, ad hoc audits resulting from referral may be limited in
scope and, therefore, all program area protocols may not be applied.
The information gathered during this program audit will be used by
the Medicare Parts C and D Oversight and Enforcement Group (MOEG)
within the Center for Medicare (CM) and CMS Regional Offices to assess
sponsoring organizations' compliance with Medicare program
requirements. If outliers or other data anomalies are detected,
Regional Offices will work in collaboration with MOEG and other
divisions within CMS for follow-up and resolution. Additionally, MA and
Part D organizations will receive the audit results and will be
required to implement corrective action to correct any identified
deficiencies. Form Number: CMS-10717 (OMB control number: 0938-1395);
Frequency: Yearly; Affected Public: Private Sector, State, Local, or
Tribal Governments, Federal Government, Business or other for-profits,
Not-for-Profit Institutions; Number of Respondents: 182; Total Annual
Responses: 182; Total Annual Hours: 36,444. (For policy questions
regarding this collection contact Matthew Guerand, at 303-844-7120.)
Dated: October 11, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2023-22791 Filed 10-13-23; 8:45 am]
BILLING CODE 4120-01-P
